Ashley Buchanan, DrPH

  • Associate Professor
  • Biostatistics in the Department of Pharmacy Practice
  • Phone: 401.874.4739
  • Email: buchanan@uri.edu
  • Office Location: Avedisian Hall
  • Website

Biography

Dr. Ashley Buchanan is an Associate Professor of Biostatistics in the Department of Pharmacy Practice, specializing in the areas of epidemiology and causal inference.  She brings over ten years of experience collaborating on HIV/AIDS research working closely with colleagues both domestically and internationally to develop and apply causal methodology to improve treatment and prevention of HIV/AIDS.

More recently, her substantive research area has expanded to studying opioid use disorder employing a variety of “big data” sources, including administrative claims data and the prescription drug monitoring programs. Her current methodological research focuses on the development and application of causal inference methods for network-based studies of HIV treatment and prevention among people who inject drugs. 

Research

Causal inference; Generalizability; Interference/Dissemination; Network Science; Observational studies;  Longitudinal analysis; HIV/AIDS; Substance use disorder prevention and treatment; Opioid crisis  

Education

Postdoctoral Research Fellow, Harvard T.H. Chan School of Public Health, 2016
DrPH, University of North Carolina at Chapel Hill, 2015
MS, Harvard University, 2007
BS, University of Massachusetts, Amherst, 2005

Selected Publications

Ashley Buchanan, Sten Vermund, Samuel Friedman, and Donna Spiegelman. (2018) Assessing individual and disseminated effects in network-randomized studies. In Press. American Journal of Epidemiology.

Ashley Buchanan, Michael G. Hudgens, Stephen R. Cole, Katie Mollan, et al. (2018) Generalizing evidence from randomized trials using inverse probability of sampling weights. Journal of the Royal Statistical SocietySeries A181(4), 1193-1209.

 Kellye Donovan, Stephen Kogut, Ashley Buchanan, Xuerong Wen, et al. (2018) Tramadol for Acute Pain in Patients Prescribed Buprenorphine/Naloxone for Opioid Use Disorder. In Press. Journal of Opioid Management.

Christopher Sudfeld, Ashley Buchanan, Nzovu Ulenga, Donna Spiegelman, et al. (2018) Implementation of routine multivitamin supplementation decreases mortality and improves HIV-related outcomes for Tanzanian HIV-infected adults enrolled in HIV treatment and care. In Press. AIDS.

Emily Patry, Jeffrey P. Bratberg, Ashley Buchanan, Andrea L. Paivab, Sara Balestrierib, Kelly L. Matson. (2018). Rx for Addiction and Medication Safety: An Evaluation of Teen Education for Opioid Misuse Prevention. In Press. Research in Social and Administrative Pharmacy.

Virginia Lemay, John Hoolahan, and Ashley Buchanan (2018). SAMYAMA: Stress, anxiety, and mindfulness: a yoga and meditation assessment. In Press. American Journal of Pharmaceutical Education.

 Ashley Buchanan, Michael Hudgens, and Stephen Cole. (2017) Generalizing evidence from HIV trials using inverse sampling weights. In: Quantitative Methods for HIV/AIDS Research (In Press). New York: CRC Press.

Catherine Lesko, Ashley Buchanan, Daniel Westreich, Jessie K. Edwards, et al. (2017) Practical considerations when generalizing study results: A potential outcomes perspective. Epidemiology, 28(4), 553-561.

Hilary Aroke, Ashley Buchanan, Xuerong Wen, Peter Ragosta, et al. (2017) Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program. In Press. Journal of Managed Care and Specialty Pharmacy.

Ashley Buchanan, Michael G. Hudgens, Stephen R. Cole, Bryan Lau, and Adaora A. Adimora (2014) Worth the weight: Using inverse probability weighted Cox models in AIDS research. AIDS Research and Human Retroviruses, 30.12, 1170-1177.

Chad Achenbach, Ashley Buchanan, Steve Cole, Hou L, et al. (2014) HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. Clinical Infectious Diseases, 58 (11), 1599-606.

Buchanan, A, Hudgens, M, Cole S. “Generalizing evidence from HIV trials using inverse sampling weights”. In: Quantitative Methods for HIV/AIDS Research, In Press (2016).

Lesko C, Buchanan A, Westreich D, Edwards J, Hudgens, M, Cole S. Practical considerations when generalizing study results: a potential outcomes perspective. Epidemiology, In Press (2016)

Buchanan A, Hudgens MG, Cole SR, Lau B, Adimora AA. Worth the weight: using inverse probability weighted Cox models in AIDS research. AIDS Research and Human Retroviruses. 2014;30(12):1170-7. PMCID: PMC4250953.

Achenbach CJ, Buchanan A, Cole SR, Hou L, Mugavero MJ, Crane HM, Moore RD, Haubrich RH, Gopal S, Eron JJ, Hunt PW, Rodriguez B, Mayer K, Saag MS, Kitahata MM. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. Clinical Infectious Diseases. 2014;58(11):1599-606. PMCID: PMC4017888.

Zhou Z, Yu F, Buchanan A, Fu Y, Campos M, Wu KK, Chambless LE, Folsom AR, Boerwinkle E, Dong JF. Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts. PLoS One. 2014;9(1):e84810. PMCID: PMC3894939.

Rice ML, Zeldow B, Siberry GK, Purswani M, Malee K, Hoffman HJ, Frederick T, Buchanan A, Sirois PA, Allison SM, Williams PL. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants. The Pediatric Infectious Disease Journal. 2013;32(10):e406-13. PMCID: PMC3785009.

Rice ML, Buchanan A, Siberry GK, Malee KM, Zeldow B, Frederick T, Purswani MU, Hoffman HJ, Sirois PA, Smith R, Torre P, 3rd, Allison SM, Williams PL. Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected. J Dev Behav Pediatr. 2012;33(2):112-23. PMCID: PMC3310927.

Torre P, Zeldow B, Hoffman HJ, Buchanan A, Siberry GK, Rice M, Sirois PA, Williams PL. Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. The Pediatric Infectious Disease Journal. 2012;31(8):835-41. PMCID: PMC3410657.

Buchanan A, Montepiedra G, Sirois PA, Kammerer B, Garvie PA, Storm DS, Nichols SL. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244-51. PMCID: PMC3340587.

Campos M, Buchanan A, Yu F, Barbalic M, Xiao Y, Chambless LE, Wu KK, Folsom AR, Boerwinkle E, Dong JF. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Blood. 2012;119(8):1929-34. PMCID: PMC3293647.

Argiris A, Buchanan A, Brockstein B, Kolesar J, Ghebremichael M, Pins M, et al. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer. Cancer. 2009;115(19):4504-13. PMCID: PMC2749918